CIK 0001386570
- Large accelerated filer
Niagen Bioscience, Inc.
Sign in to watch- Ticker
- NAGE
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262940963
- Phone
- +1 310-388-6706
- Business address
- 10900 WILSHIRE BLVD, SUITE 600, LOS ANGELES, CA, 90024
- Former names
- ChromaDex Corp., CODY RESOURCES, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-25 | FARR KEVIN M CHIEF FINANCIAL OFFICER | Grant or award · Employee Stock Options (right to buy) | +109,054 | 109,054 | ||
| 2020-02-25 | Jaksch Frank L Jr EXECUTIVE CHAIRMAN OF BOARD | Grant or award · Employee Stock Options (right to buy) | +74,048 | 74,048 | ||
| 2020-02-25 | Friedman Mark J GENERAL COUNSEL | Grant or award · Employee Stock Options (right to buy) | +109,054 | 109,054 | ||
| 2020-02-25 | Fried Robert N CEO | Grant or award · Employee Stock Options (right to buy) | +165,155 | 165,155 | ||
| 2019-11-14 | Fried Robert N CEO | Purchase | +10,000 | $3.09 | $31K | 1,444,315 |
| 2019-08-23 | Fried Robert N CEO | Purchase | +2,500 | $4.03 | $10K | 1,436,327 |
| 2019-06-21 | LAU Tsz Ho Tony Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2019-06-21 | BLOCK STEPHEN A Director | Grant or award · Stock Options (right to buy) | +20,000 | 20,000 | ||
| 2019-06-21 | YU Wing Tak Wendy Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2019-06-21 | Rubin Steven D Director | Grant or award · Stock Options (right to buy) | +20,000 | 20,000 | ||
| 2019-06-21 | Baxter Jeff Director | Grant or award · Stock Options (right to buy) | +20,000 | 20,000 | ||
| 2019-06-21 | GUSTAFSON KURT A Director | Grant or award · Stock Options (right to buy) | +20,000 | 20,000 | ||
| 2019-05-21 | Fried Robert N CEO | Purchase | +2,253 | $4.43 | $10K | 1,433,827 |
| 2019-03-15 | FARR KEVIN M CHIEF FINANCIAL OFFICER | Purchase | +6,900 | $3.85 | $27K | 36,625 |
| 2019-03-15 | Fried Robert N CEO | Purchase | +5,000 | $3.80 | $19K | 1,431,574 |
| 2019-03-14 | FARR KEVIN M CHIEF FINANCIAL OFFICER | Purchase | +6,725 | $3.99 | $27K | 29,725 |
| 2019-03-13 | Fried Robert N CEO | Grant or award | +166,666 | 1,426,574 | ||
| 2019-03-12 | FARR KEVIN M CHIEF FINANCIAL OFFICER | Purchase | +7,300 | $3.62 | $26K | 23,000 |
| 2019-03-11 | FARR KEVIN M CHIEF FINANCIAL OFFICER | Purchase | +5,700 | $3.49 | $20K | 15,700 |
| 2019-03-11 | Jaksch Frank L Jr EXECUTIVE CHAIRMAN OF BOARD | Exercise or conversion | +33,334 | $1.50 | $50K | 234,891 |
Page 7 of 12 · 238 trades